Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Candel Therapeutics (CADL) Total Debt: 2020-2023

Historic Total Debt for Candel Therapeutics (CADL) over the last 2 years, with Sep 2023 value amounting to $20.4 million.

  • Candel Therapeutics' Total Debt rose 1.58% to $20.4 million in Q3 2023 from the same period last year, while for Sep 2023 it was $20.4 million, marking a year-over-year increase of 1.58%. This contributed to the annual value of $20.2 million for FY2022, which is 3507.50% up from last year.
  • Candel Therapeutics' Total Debt amounted to $20.4 million in Q3 2023, which was up 0.41% from $20.4 million recorded in Q2 2023.
  • Candel Therapeutics' Total Debt's 5-year high stood at $20.4 million during Q3 2023, with a 5-year trough of $463,000 in Q4 2020.
  • Moreover, its 3-year median value for Total Debt was $20.2 million (2022), whereas its average is $17.7 million.
  • Data for Candel Therapeutics' Total Debt shows a peak YoY spiked of 3,507.50% (in 2022) over the last 5 years.
  • Over the past 4 years, Candel Therapeutics' Total Debt (Quarterly) stood at $463,000 in 2020, then climbed by 20.95% to $560,000 in 2021, then skyrocketed by 3,507.50% to $20.2 million in 2022, then grew by 1.58% to $20.4 million in 2023.
  • Its Total Debt was $20.4 million in Q3 2023, compared to $20.4 million in Q2 2023 and $20.3 million in Q1 2023.